USP Sterile Semisynthetic Broad-Spectrum, Cephalosporin Cefuroxime Sodium for Injection

• Customization: Available
• Application: Surgery
• Usage Mode: Intramuscular Administration
• Model NO.: 750mg
• Suitable for: Adult
• State: Solid
• Shape: Powder
• Type: Biological Products
• Pharmaceutical Technology: Chemical Synthesis
• Function: Reduce The Development of Drug-Resistant Bacteria
• Dosage Form: Color From Light Yellow to Amber
• Transport Package: as Per Customerized
• Specification: 500mg/1g
• Trademark: No
• Origin: China
• HS Code: 3004909099
• Production Capacity: 10, 000, 000 Vials

Product Description

Rx Only 

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cefuroxime for Injection and other antibacterial drugs, Cefuroxime for Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

The drug is a kind of white or light yellow powder or crystallized powder.The drug is indicated for the treatment of the respiratory tract and otorhinolaryngological infection and so on.
for I.V or I.M

Indications

Respiratory tract infections	acute and chronic bronchitis, infectious bronchitis, bacterial pneumonia, pulmonary abscess, and postoperative chest infections
ears, nose, and throat infection	sinusitis, tonsillitis, pharyngitis
urinary tract infections	acute, chronic pyelonephritis, cystitis and asymptomatic bacteriuria.
skin and soft tissue infections	cellulitis, erysipelas, peritonitis and wound infection.
bone and joint infections	osteomyelitis and septic arthritis
obstetrics and gynecological infections	pelvic inflammatory disease
gonorrhea	especially suitable for use in the treatment of penicillin
other infections	including sepsis and meningitis; abdominal pelvic and orthopedic surgery; Heart, lung, esophagus and vascular surgery; total joint replacement surgery to prevent infection.

Cefuroxime for Injection, USP is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases:

1. Lower Respiratory Tract Infections, including pneumonia, caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, and Escherichia coli.
2. Urinary Tract Infections caused by Escherichia coli and Klebsiella spp.
3. Skin and Skin­-Structure Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, Escherichia coli, Klebsiella spp., and Enterobacter spp.
4. Septicemia caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae (including ampicillin-resistant strains), and Klebsiella spp.
5. Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Neisseria meningitidis, and Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).
6. Gonorrhea: Uncomplicated and disseminated gonococcal infections due to Neisseria gonorrhoeae (penicillinase- and non-penicillinase-producing strains) in both males and females.
7. Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).

Package
(1) 1 bottles / box (0.75g); (2) 10 bottles / box; (3) 6 bottles / box (2.0g, 2.25g, 2.5G, 3.0g).

Storage
Keep  in dark place and tight package, Store in cool ( under a temperatyre of 20° C )